Skip Navigation LinksHome > April 2006 - Volume 25 - Issue 4 > LOW IMMUNOLOGIC RESPONSE TO HIGHLY ACTIVE ANTIRETROVIRAL THE...
Pediatric Infectious Disease Journal:
doi: 10.1097/01.inf.0000207419.50016.5e
Brief Reports

LOW IMMUNOLOGIC RESPONSE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN NAIVE VERTICALLY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-INFECTED CHILDREN WITH SEVERE IMMUNODEFICIENCY

Resino, Salvador PhD*; Alvaro-Meca, Alejandro MSc*; de José, Maria Isabel MD‡; Martin-Fontelos, Pablo MD§; Gutiérrez, Maria Dolores Gurbindo MD†; Léon, Juan Antonio MD∥; Ramos, José Tomás MD¶; Ciria, Luis MD#; Muñoz-Fernández, Maria Ángeles PhD*,1

Collapse Box

Abstract

We conducted a retrospective study to analyze the CD4+ recovery of naive vertically human immunodeficiency virus-infected children with severe immunodeficiency who were followed up during at least 4 years of receiving highly active antiretroviral therapy (HAART). Children with baseline CD4+ of <15% did not reach a mean CD4+ of ≥25% after the 4th year on HAART. We conclude that starting HAART after severe immunosuppression of naive HIV-infected children may not be effective for recovery of normal %CD4+.

© 2006 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.